[Treatment of status epilepticus in children with epilepsy]

Area of Science:

• Pediatric Neurology
• Epileptology
• Clinical Pharmacology

Context:

• Status epilepticus (SE) management in children presents unique challenges based on epilepsy syndromes.
• Certain treatments, like IV barbiturates or IV benzodiazepines, can exacerbate specific epilepsy types, such as severe myoclonic epilepsy in infancy (SMEI) or Lennox-Gastaut syndrome.
• Intensive care is not universally required for all SE cases, particularly non-convulsive SE (NCSE).

Purpose:

• To outline syndrome-specific treatment strategies for pediatric status epilepticus.
• To differentiate management protocols for convulsive SE (CSE) and non-convulsive SE (NCSE).
• To emphasize the importance of accurate diagnosis and timely intervention in pediatric SE.

Summary:

• Treatment for pediatric SE must be tailored to the underlying epilepsy syndrome to prevent drug-induced worsening.
• Generalized CSE, often seen in SMEI, symptomatic generalized epilepsy, and partial lesional epilepsy, requires emergency treatment with IV benzodiazepines and potentially IV phenytoin.
• Partial CSE and NCSE, including absence and myoclonic SE, are frequently underdiagnosed, especially in infants, and are managed with IV benzodiazepines, with diagnosis confirmed by video EEG.

Impact:

• Informed clinical decision-making for pediatric SE, potentially improving patient outcomes.
• Reduced risk of adverse events associated with inappropriate SE treatments.
• Enhanced recognition and management of underdiagnosed NCSE in infants and children.